HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang Hu Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

2/2024circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation.
1/2024Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity.
6/2023EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway.
1/2021NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway.
1/2021Corrigendum: NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway.
8/2013Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang Hu Research Topics

Disease

81Neoplasms (Cancer)
03/2024 - 07/2003
25Stomach Neoplasms (Stomach Cancer)
04/2024 - 09/2009
24Insulin Resistance
01/2024 - 10/2010
21Inflammation (Inflammations)
04/2024 - 04/2010
19Neoplasm Metastasis (Metastasis)
03/2024 - 05/2010
12Obesity
05/2022 - 02/2012
11Type 2 Diabetes Mellitus (MODY)
10/2023 - 05/2015
10Non-alcoholic Fatty Liver Disease
08/2023 - 02/2012
10Osteosarcoma (Osteogenic Sarcoma)
04/2022 - 05/2010
10Carcinogenesis
08/2021 - 01/2006
9Fibrosis (Cirrhosis)
04/2024 - 04/2016
9Wounds and Injuries (Trauma)
05/2021 - 10/2009
8Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2022 - 01/2020
7Body Weight (Weight, Body)
03/2024 - 04/2011
7Breast Neoplasms (Breast Cancer)
12/2023 - 03/2013
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 08/2013
6Hepatocellular Carcinoma (Hepatoma)
06/2023 - 08/2014
5Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 03/2018
5Infections
08/2023 - 01/2013
5Ischemia
08/2023 - 01/2015
5Hypertension (High Blood Pressure)
11/2022 - 01/2018
5Colonic Neoplasms (Colon Cancer)
01/2022 - 05/2013
5Colitis
01/2022 - 01/2016
5Atherosclerosis
01/2021 - 06/2015
5Endometrial Neoplasms (Endometrial Cancer)
11/2020 - 07/2017
5Rectal Neoplasms (Rectal Cancer)
01/2019 - 06/2010
5Glioma (Gliomas)
01/2019 - 03/2011
4COVID-19
07/2022 - 01/2020
4Lymphatic Metastasis
12/2021 - 03/2007
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 01/2015
4Glioblastoma (Glioblastoma Multiforme)
01/2017 - 05/2013
4Adenoid Cystic Carcinoma (Cylindroma)
01/2012 - 07/2010
3Hyperglycemia
05/2024 - 06/2015
3Hypertrophy
04/2024 - 10/2020
3Diabetic Cardiomyopathies
04/2024 - 11/2020
3Lung Neoplasms (Lung Cancer)
02/2024 - 07/2017
3Diabetic Foot
10/2023 - 01/2021
3Ulcer
10/2023 - 01/2021
3Atrophy
01/2023 - 01/2011
3Alzheimer Disease (Alzheimer's Disease)
01/2023 - 11/2015
3Margins of Excision
10/2022 - 08/2016
3Thrombocytopenia (Thrombopenia)
10/2022 - 01/2021
3Acute Liver Failure (Fulminant Hepatic Failure)
07/2022 - 09/2014
3Diabetes Mellitus
07/2022 - 09/2018
3Carcinoma (Carcinomatosis)
01/2021 - 08/2013
3Hypoxia (Hypoxemia)
03/2020 - 07/2017

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2010
19Glucose (Dextrose)FDA LinkGeneric
05/2024 - 10/2010
17Biomarkers (Surrogate Marker)IBA
12/2023 - 05/2010
12LipidsIBA
07/2022 - 04/2011
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 04/2010
10CytokinesIBA
08/2023 - 01/2013
10Peptides (Polypeptides)IBA
08/2023 - 10/2012
9Insulin (Novolin)FDA Link
05/2024 - 10/2010
9Transcription Factors (Transcription Factor)IBA
01/2019 - 02/2009
8Messenger RNA (mRNA)IBA
01/2022 - 12/2011
8IntegrinsIBA
11/2020 - 01/2014
7Small Interfering RNA (siRNA)IBA
11/2022 - 01/2015
7Inosine Triphosphate (ITP)IBA
10/2022 - 01/2020
7Caspase 3 (Caspase-3)IBA
07/2022 - 05/2011
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2018 - 08/2010
6AlbuminsIBA
05/2023 - 02/2015
6Therapeutic UsesIBA
01/2023 - 01/2012
6Indicators and Reagents (Reagents)IBA
01/2022 - 04/2014
6InflammasomesIBA
04/2021 - 01/2013
6CateninsIBA
01/2017 - 02/2013
5CurcuminIBA
03/2024 - 01/2011
5Interleukin-10 (Interleukin 10)IBA
11/2020 - 10/2012
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2019 - 10/2013
4ParaffinIBA
03/2024 - 05/2010
4Triglycerides (Triacylglycerol)IBA
10/2023 - 07/2017
4Interleukin-6 (Interleukin 6)IBA
07/2022 - 07/2010
4FHDIBA
01/2022 - 10/2016
4CollagenIBA
08/2020 - 09/2011
4Fibroblast Growth Factor-23IBA
01/2018 - 11/2015
3RNA (Ribonucleic Acid)IBA
04/2024 - 01/2020
3Blood Glucose (Blood Sugar)IBA
03/2024 - 01/2018
3Formaldehyde (Formol)FDA Link
03/2024 - 05/2010
3Immune Checkpoint InhibitorsIBA
12/2023 - 01/2020
3MicroRNAs (MicroRNA)IBA
06/2023 - 08/2013
3AntioxidantsIBA
12/2022 - 07/2012
3C-Reactive ProteinIBA
07/2022 - 01/2018
3Radioisotopes (Radionuclides)IBA
01/2022 - 05/2014
3Dextran SulfateIBA
01/2022 - 01/2016
3oxidized low density lipoproteinIBA
11/2021 - 07/2019
3Phosphotransferases (Kinase)IBA
10/2021 - 08/2010
3InterferonsIBA
01/2021 - 05/2015
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2015
3isoliquiritigenin (GU 17)IBA
11/2020 - 08/2010

Therapy/Procedure

37Therapeutics
12/2023 - 03/2011
16Gastrectomy
04/2024 - 03/2007
13Drug Therapy (Chemotherapy)
02/2024 - 05/2011
10Transplantation
01/2022 - 10/2008
8Lymph Node Excision (Lymph Node Dissection)
04/2024 - 03/2007
5Immunotherapy
12/2023 - 10/2013
5Negative-Pressure Wound Therapy
01/2018 - 10/2013
4Radiotherapy
01/2023 - 11/2017
4Adjuvant Chemotherapy
01/2022 - 01/2019
4Stem Cell Transplantation
01/2015 - 02/2013
3Precision Medicine
01/2022 - 05/2014